Login
Login     |     Register     |     Recover Username/Password

General Investing

On Even REIT Playing Field, Earnings Differentiators Step Up

February 07, 2011

Multifamily REITs outperformed last year, and 2011 calls for 10% to 12% total returns for the industry overall. But with much of the sector’s ability to drive NOI growth already built into the stocks’ valuations, Analyst Andrew DiZio of Janney Montgomery Scott is focusing on REITs that are earnings growth differentiators.

“We think if supply is going to be even and job growth is going to be lackluster everywhere, and the big driver of growth has been falling homeownership rates, again we’ve seen that everywhere,” DiZio said. “So we need to invest in multifamily REITs that have some sort of differentiated drivers besides just being to able to say, ‘Well, I’m raising rents.’ I think everyone is going to raise rents somewhere close to equally.”

DiZio’s two picks for multifamily are Essex Property Trust (ESS) and Home Properties (HME). While development wanes, Essex will benefit through 2011 from the purchase of vacant buildings leased up as Class A apartments. Similarly, Home Properties‘ strategy is to purchase Class C apartments and upgrade them.

“Home is really the only multifamily REIT that really has that strategic focus, and what that has historically done is it has resulted in about an additional 100 basis points of same-store NOI above where their peers are,” DiZio said. “When you go back and you look at the last 10 years in terms of same-store NOI growth, Home Properties has actually seen the greatest average annual same-store NOI growth of any multifamily REIT over that 10-year period — 3.7%.”


TSWT - Subscribe now!

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Over 20,000 CEO, Equity Analyst and Money Manager Interviews

TWST Newsletter

Weekly email with New In-Depth Interviews

Most Popular Interviews
Opportunities in Hepatitis C and Genomic Technologies
David Ferreiro

Published April 26, 2014 in Biotechnology and Pharmaceuticals

Buy ($75)
Investing in Health Care Innovation
Finny Kuruvilla

"We’re a faith-based and socially responsible investing firm"

Published May 16, 2013 in Investing in Health Care

Buy ($75)
A Health Sciences Fund with a Long-Term Focus
Mark W. Oelschlager

"The fund is about $40 million in assets"

Published May 16, 2013 in Investing in Health Care

Buy ($75)
High-Yield Canadian Power Companies
John McIlveen

Published May 14, 2013 in High-Yield Equity Securities

Buy ($75)
Most Popular Reports
Investing in Health Care

Published May 16, 2013

Topics Covered: Health Care - Electronic Health Record Adoption - Biotechnology and Pharmaceutical Investing - Biotechnology and Pharmaceuticals - Biotechnology and Pharmaceutical Companies Valuation - Platform Interoperability and Data Analytics - HITECH Act Incentives - Affordable Care Act
Buy ($175)
Internet Services

Published May 10, 2013

Topics Covered: Increased Mobile Content Traffic - Chinese Online Monetization Trends - Internet Infrastructure and Services Consolidation - Social Networking Economics -
Buy ($175)
Investing Strategies

Published May 10, 2013

Topics Covered: Investing in Financial Services - Long-Term Investing - Large Cap Investing - Value Investing - High Quality Companies - Bottom-up Investing - All-Cap Growth Investing - Investing in Emerging Markets
Buy ($175)
Top Company Interviews
TWST
Register for a Free Account to gain greater access to The Wall Street Transcript right now